Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era

Cancer

Volumn 120, Issue 11, 2014, Pages 1725-1732

  Devaki, Pardha ^a   Wong, Robert J ^b   Marupakula, Vidyasagargoud ^a   Nangia, Sharad ^c   Nguyen, Long ^b   Ditah, Ivo C ^d   Ehrinpreis, Murray N ^c   Nguyen, Mindie H ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

liver transplantation; localized hepatocellular carcinoma; Model for End stage Liver Disease; SEER; survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER LOCALIZATION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PACIFIC ISLANDER; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

LIVER TRANSPLANTATION; LOCALIZED HEPATOCELLULAR CARCINOMA; MODEL FOR END-STAGE LIVER DISEASE; SEER; SURVIVAL ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 84901297389     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28639     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. GLOBOCAN, version 2.0: Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10. Lyon, France: International Agency for Research on Cancer; 2010. globocan.iarc.fr. Accessed on February 21, 2013.
2. Forner A, Llovet JM, Bruix J,. Hepatocellular carcinoma. Lancet. 2012; 379: 1245-1255.
3. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
4. Altekruse SF, McGlynn KA, Reichman ME,. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009; 27: 1485-1491.
5. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ,. Liver transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10 (4 pt 2): 1003-1019.
6. Ioannou GN, Perkins JD, Carithers RL Jr,. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008; 134: 1342-1351.
7. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov. 2011 Sub (1973-2009)-Linked To County Attributes-Total US, 1969-2010 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2012, based on the November 2011 submission.
8. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
9. Mantel N,. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163-170.
10. Cox DR,. Regression models and life-tables. J R Stat Soc B. 1972; 34: 187-220.
11. National Cancer Institute. Surveillance Research Program, National Cancer Institute SEER*Stat software. Version 8.0.1. seer.cancer.gov/seerstat. Access date.
12. StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
13. Tan D, Yopp A, Beg MS, Gopal P, Singal AG,. Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2013; 38: 703-712.
14. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE,. Hepatocellular carcinoma confirmation, treatment, and survival in Surveillance, Epidemiology, and End Results registries, 1992-2008. Hepatology. 2012; 55: 476-482.
15. Cance WG, Stewart AK, Menck HR,. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996. Cancer. 2000; 88: 912-920.
16. Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF,. Underutilization of therapy for hepatocellular carcinoma in the Medicare population. Cancer. 2011; 117: 1019-1026.
17. Zak Y, Rhoads KF, Visser BC,. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg. 2011; 146: 778-784.
18. Wang J, Wang FW,. Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma. Int J Surg Oncol. 2010; 2010: 381795.
19. O'Connell JB, Maggard MA, Ko CY,. Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol. 2004; 11: 962-969.
20. Yeh CN, Lee WC, Jeng LB, Chen MF,. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology. 2004; 51: 219-223.
21. Tsukioka G, Kakizaki S, Sohara N, et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol. 2006; 12: 48-53.
22. Pignata S, Gallo C, Daniele B, et al; CLIP Investigators. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol. 2006; 59: 243-249.
23. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ,. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008; 300: 2371-2378.
24. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias. Am J Transplant. 2007; 7: 685-692.
25. Lai JC, Terrault NA, Vittinghoff E, Biggins SW,. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010; 10: 2658-2664.
26. Sloane D, Chen H, Howell C,. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006; 98: 1934-1939.
27. Guidry JJ, Aday LA, Zhang D, Winn RJ,. Cost considerations as potential barriers to cancer treatment. Cancer Pract. 1998; 6: 182-187.
28. Nathan H, Schulick RD, Choti MA, Pawlik TM,. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg. 2009; 249: 799-805.
29. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ,. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg. 2010; 145: 1158-1163.
30. Yip B, Wantuck JM, Kim LH, Wong RJ, Ahmed A, Garcia G, Nguyen MH,. Clinical Presentation and survival of Asian and Non-Asian patients with HCV-related hepatocellular carcinoma. Dig Dis Sci. 2014; 59: 192-200.